skip navigation

PUBLICATIONS

Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.

 

NCJ Number: 202737 Find in a Library
Title: Fenethylline and the Middle East: A Brief Summary
Corporate Author: Drug Enforcement Admin
US Dept of Justice
United States of America
Date Published: September 2003
Page Count: 4
Sponsoring Agency: Drug Enforcement Admin
Springfield, VA 22152
Publication Number: DEA-03046
Sale Source: Drug Enforcement Admin
US Dept of Justice
8701 Morrissette Drive
Springfield, VA 22152
United States of America
Document: PDF
Type: Issue Overview
Format: Document (Online)
Language: English
Country: United States of America
Annotation: This overview of fenethylline trafficking and use in the Middle East considers the drug's legal status in the United States, its physiological effects, the prevalence of its abuse, production and trafficking, and emerging trends.
Abstract: Fenethylline, commonly known by the trademark name Captagon, is a synthetic amphetamine-type stimulant that has been clandestinely produced in southern Europe and trafficked through Turkey to the consumer markets on the Arabian Peninsula. It is one of the most popular drugs of abuse among the young affluent populations of the Middle East. Fenethylline is a central nervous system stimulant with effects similar to amphetamine. In small to moderate doses, it causes elevations in heart rate, body temperature, respiration, and blood pressure. Over the long-term, amphetamine use can have a number of side effects, including, but not limited to, extreme depression, lethargy, sleep deprivation, heart and blood vessel toxicity, and malnutrition. Authorities in Saudi Arabia, Kuwait, and Qatar report that the use of fenethylline is prevalent among their younger, affluent citizens. In the United State fenethylline has been a controlled substance on Schedule I of the Controlled Substances Act since 1981. It does not have an accepted medical use in the United States and is not approved for distribution. According to open source reporting, counterfeit Captagon tablets have been reported in Saudi Arabia since the late 1980's. The majority of these tablets have contained mixtures of drugs capable of inducing effects similar to those of fenethylline. As available stocks of diverted fenethylline are depleted and the availability of chemicals for the clandestine production of the drug fluctuate, increasing amounts of counterfeit Captagon will likely be the trend.
Main Term(s): Drug information
Index Term(s): Amphetamines; Drug abuse; Drug effects; Drug laws; Drug smuggling; Middle East
Note: Downloaded November 6, 2003.
To cite this abstract, use the following link:
http://www.ncjrs.gov/App/publications/abstract.aspx?ID=202737

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.